UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 170 filers reported holding UNIQURE NV in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,082,969 | -68.9% | 356,280 | -45.4% | 0.16% | -68.0% |
| Q1 2023 | $13,140,262 | -11.2% | 652,446 | 0.0% | 0.50% | -10.6% |
| Q4 2022 | $14,790,951 | +51.1% | 652,446 | +25.1% | 0.56% | +39.4% |
| Q3 2022 | $9,787,000 | +0.6% | 521,693 | 0.0% | 0.40% | +5.0% |
| Q2 2022 | $9,724,000 | +3.2% | 521,693 | 0.0% | 0.38% | +15.4% |
| Q1 2022 | $9,427,000 | -12.9% | 521,693 | 0.0% | 0.33% | -4.9% |
| Q4 2021 | $10,820,000 | +42.6% | 521,693 | +120.1% | 0.35% | +42.6% |
| Q3 2021 | $7,587,000 | +9.0% | 237,008 | +4.9% | 0.24% | +8.0% |
| Q2 2021 | $6,958,000 | +65.2% | 225,921 | +80.7% | 0.23% | +55.9% |
| Q1 2021 | $4,211,000 | -6.8% | 125,003 | 0.0% | 0.14% | -8.8% |
| Q4 2020 | $4,516,000 | +94.5% | 125,003 | +98.3% | 0.16% | +82.8% |
| Q3 2020 | $2,322,000 | -18.3% | 63,039 | 0.0% | 0.09% | -19.4% |
| Q2 2020 | $2,841,000 | +36.5% | 63,039 | +43.8% | 0.11% | +14.9% |
| Q1 2020 | $2,081,000 | -59.2% | 43,849 | -38.4% | 0.09% | -51.3% |
| Q4 2019 | $5,102,000 | +195.6% | 71,191 | +62.4% | 0.19% | +157.3% |
| Q3 2019 | $1,726,000 | +11.8% | 43,849 | +122.0% | 0.08% | +19.0% |
| Q2 2019 | $1,544,000 | +31.1% | 19,751 | 0.0% | 0.06% | +31.2% |
| Q1 2019 | $1,178,000 | +8.3% | 19,751 | -47.7% | 0.05% | +2.1% |
| Q4 2018 | $1,088,000 | -20.8% | 37,741 | 0.0% | 0.05% | -6.0% |
| Q3 2018 | $1,373,000 | -3.8% | 37,741 | 0.0% | 0.05% | -7.4% |
| Q2 2018 | $1,427,000 | -69.6% | 37,741 | -81.1% | 0.05% | -70.5% |
| Q1 2018 | $4,694,000 | -28.0% | 199,750 | -40.0% | 0.18% | -27.4% |
| Q4 2017 | $6,521,000 | +181.8% | 332,850 | +38.1% | 0.25% | +203.6% |
| Q3 2017 | $2,314,000 | +55.1% | 241,021 | 0.0% | 0.08% | +50.9% |
| Q2 2017 | $1,492,000 | +7.1% | 241,021 | 0.0% | 0.06% | +1.9% |
| Q1 2017 | $1,393,000 | +3.2% | 241,021 | 0.0% | 0.05% | -6.9% |
| Q4 2016 | $1,350,000 | -26.8% | 241,021 | 0.0% | 0.06% | -18.3% |
| Q3 2016 | $1,844,000 | +3.8% | 241,021 | 0.0% | 0.07% | -1.4% |
| Q2 2016 | $1,776,000 | -38.0% | 241,021 | 0.0% | 0.07% | -41.0% |
| Q1 2016 | $2,863,000 | -1.4% | 241,021 | +37.3% | 0.12% | +16.2% |
| Q4 2015 | $2,903,000 | -30.9% | 175,500 | -14.6% | 0.10% | -30.9% |
| Q3 2015 | $4,204,000 | – | 205,600 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |